Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

263
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
263
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

1.4K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.4K
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

303
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
303
Schizophrenia01:17

Schizophrenia

493
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
493
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

616
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
616
Drug Therapy01:28

Drug Therapy

154
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
154

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automated Speech-Based Modeling of Item-Level Symptom Severity in Schizophrenia.

JAMA network open·2026
Same author

Does ChatGPT need a psychiatrist? Similarities between human psychopathology and errors in large language models.

NPP - digital psychiatry and neuroscience·2026
Same author

Citalopram serum concentrations in men and women of pre- and post-menopausal age.

Expert opinion on drug metabolism & toxicology·2026
Same author

The global economic burden of schizophrenia: an umbrella review of systematic reviews and meta-analyses with reconstructed primary-study cost data.

Health economics review·2026
Same author

Women and psychosis: a guide to evidence-based, hormone-informed care.

The lancet. Psychiatry·2026
Same author

Practical Approach to Hormone Replacement Therapy for (Peri) Menopausal Women With Schizophrenia Spectrum Disorders: A Case Series.

Schizophrenia bulletin·2026

Related Experiment Video

Updated: Nov 18, 2025

Protocol for Studying Extinction of Conditioned Fear in Naturally Cycling Female Rats
09:07

Protocol for Studying Extinction of Conditioned Fear in Naturally Cycling Female Rats

Published on: February 23, 2015

13.7K

Estrogens in schizophrenia: progress, current challenges and opportunities.

Bodyl A Brand1, Janna N de Boer1,2, Iris E C Sommer1

  • 1University of Groningen, Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, Groningen.

Current Opinion in Psychiatry
|February 9, 2021
PubMed
Summary

Estrogens play a crucial role in schizophrenia, influencing symptoms and antipsychotic effectiveness. Estrogen deficiency exacerbates symptoms, while estrogen levels impact medication efficacy, particularly in women.

More Related Videos

Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model
05:32

Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model

Published on: August 11, 2023

2.2K
Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

1.1K

Related Experiment Videos

Last Updated: Nov 18, 2025

Protocol for Studying Extinction of Conditioned Fear in Naturally Cycling Female Rats
09:07

Protocol for Studying Extinction of Conditioned Fear in Naturally Cycling Female Rats

Published on: February 23, 2015

13.7K
Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model
05:32

Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model

Published on: August 11, 2023

2.2K
Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

1.1K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Endocrinology

Background:

  • Schizophrenia presents differently in men and women, with estrogens implicated as a protective factor.
  • Estrogen deficiency is linked to increased psychotic symptoms in schizophrenia patients.
  • Estrogens modulate key pathways in schizophrenia, including dopamine activity and stress response.

Purpose of the Study:

  • To review the current understanding of estrogen's role in schizophrenia pathophysiology.
  • To examine the clinical implications of estrogen levels on treatment efficacy.
  • To identify future research directions in estrogen-related schizophrenia studies.

Main Methods:

  • Review of existing literature on estrogen and schizophrenia.
  • Analysis of estrogen's influence on neurobiological pathways.
  • Examination of clinical data regarding sex differences in schizophrenia treatment.

Main Results:

  • Estrogens regulate dopamine activity, mitochondrial function, and the stress system in schizophrenia.
  • Estrogen deficiency is common and associated with worsening psychotic symptoms.
  • Estrogens enhance antipsychotic availability and efficacy, necessitating lower doses in premenopausal women.

Conclusions:

  • Estrogens are vital in schizophrenia pathophysiology and influence clinical practice, especially antipsychotic drug efficacy.
  • Future research should investigate hormonal contraceptives and estrogen-like augmentation strategies (raloxifene, phytoestrogens) in schizophrenia treatment.
  • Understanding estrogen's role is critical for personalized schizophrenia management, particularly in women.